[Perspective for the new calcitonin preparation].
Yamauchi
Hirose
H
Japan Osteoporosis Foundation.
D000281:Administration, Intranasal; D000284:Administration, Oral; D001682:Biological Availability; D002116:Calcitonin / Q000008:administration & dosage* / Q000493:pharmacokinetics; D003094:Collagen / Q000097:blood; D024042:Collagen Type I; D004304:Dosage Forms; D005260:Female; D006801:Humans; D008297:Male; D010455:Peptides / Q000097:blood; D016032:Randomized Controlled Trials as Topic
D024042:Collagen Type I; D004304:Dosage Forms; D010455:Peptides; C052929:collagen type I trimeric cross-linked peptide; D002116:Calcitonin; D003094:Collagen